Fluoxetine

Quick links to important sections

Fluoxetine

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fluoxetine

What is Fluoxetine?

Fluoxetine is a medication that belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It is primarily used in the management of various mental health conditions, including depression, certain anxiety disorders, and obsessive-compulsive patterns.

Mechanism of Action

The medication works by influencing the chemical environment within the brain. Specifically, it increases the availability of serotonin, a neurotransmitter that facilitates communication between nerve cells. By preventing the rapid reabsorption (reuptake) of serotonin into neurons, fluoxetine helps maintain higher levels of this chemical in the synaptic gap, which is associated with improved mood and emotional regulation.

Therapeutic Use

Fluoxetine is utilized to address a range of psychological symptoms. Its primary applications include:

  • Major Depressive Disorder: Assisting in the relief of persistent sadness, loss of interest, and low energy levels.
  • Obsessive-Compulsive Disorder (OCD): Helping to reduce the frequency of intrusive thoughts and repetitive behaviors.
  • Panic Disorder: Managing the occurrence of sudden, intense physical and emotional symptoms of fear.
  • Bulimia Nervosa: Aiding in the reduction of binge-eating and purging cycles.

Because fluoxetine has a relatively long half-life compared to other medications in its class, it remains in the system for an extended period, which can contribute to a more stable concentration of the drug in the bloodstream over time.

Regulatory References

  1. NIH, MedlinePlus
  2. emotional and behavioral disturbances
  3. serotonin reuptake blockade

What side effects are possible with Fluoxetine?

Possible Side Effects and Safety Information

The official safety profile of Fluoxetine, as documented by government regulatory agencies, details a range of possible adverse reactions classified by frequency and categorized by the physiological system affected.

Frequency-Classified Adverse Reactions

Adverse events are generally grouped into system-organ classes, with effects noted across the nervous system, gastrointestinal tract, and psychiatric domain. The most frequently documented events, classified as Very Common in regulatory documents, include insomnia, headache, nausea, diarrhoea, and fatigue.

Reactions categorized as Common include nervousness, anxiety, tremor, dizziness, dry mouth, dyspepsia, and specific effects on sexual function like decreased libido.

Serious Adverse Reactions and Key Safety Constraints

Official labeling describes several serious adverse reactions. These include the potential for Serotonin Syndrome, a risk associated particularly with co-administration of other serotonergic agents. Serious dermatological reactions and conditions such as QT interval prolongation are also documented.

Regulatory documents outline specific high-level safety constraints. Fluoxetine is contraindicated for use with Monoamine Oxidase Inhibitors (MAOIs) due to the risk of a serious reaction, and caution is advised in individuals with a history of seizures or pre-existing cardiac conditions that predispose to arrhythmias.

Population-Specific and Time-Related Safety Patterns

The safety profile includes warnings related to specific patient groups and time points. An increased risk of suicidal thoughts and behavior is noted, observed mainly at the beginning of treatment or following a dose change in children, adolescents, and young adults. Hepatic impairment requires a lower or less frequent dose, and caution is advised when administering Fluoxetine to older adults due to potential issues like hyponatraemia.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes a Fluoxetine overdose profile characterized by a range of documented clinical manifestations, severe systemic outcomes, and mandated emergency actions. Overdose is generally managed as a medical emergency requiring immediate professional care.


Documented Clinical Manifestations and Severe Outcomes

Manifestations reported in regulatory documents include agitation, confusion, tremor, drowsiness, and nausea and vomiting. Systemic effects may include fever, sweating, and fast or irregular heartbeat (tachycardia).

Severe outcomes documented in official labeling that pose a life-threatening risk include seizures, coma, Serotonin Syndrome, and critical cardiac events such as QT Prolongation and Ventricular Arrhythmia (Torsades de Pointes).


Mandated Emergency Actions

Immediate medical attention is required upon any suspected overdose. Regulator-mandated guidance states that a poison control center or emergency services must be contacted right away, even if the individual appears asymptomatic.

Urgent medical help must be sought if the person experiences collapse, seizure activity, severe trouble breathing, or inability to be awakened. Treatment is supportive and symptomatic, and official labeling notes that no specific antidote is known for Fluoxetine overdose. Management involves discontinuing the drug and initiating appropriate supportive care.

Therapeutic Uses of Fluoxetine

What Fluoxetine Treats: Main Uses and Benefits

Fluoxetine is commonly used across conditions presenting with acute or disruptive symptom patterns in the domain of mental health, and may assist with managing symptoms that interfere with daily functioning. The medication is relevant for easing symptoms in conditions like Major Depressive Disorder, Panic Disorder, Obsessive-Compulsive Disorder (OCD), Bulimia Nervosa, and the severe mood shifts of Premenstrual Dysphoric Disorder (PMDD).

Supportive Management and Core Benefits

The medication is commonly used to help with groups of symptoms that may appear suddenly or intensify over time, such as persistent sadness, despair, and anhedonia characteristic of MDD. It is applied in addressing conditions marked by increased discomfort or tension, relevant for managing symptoms that interfere with daily comfort, such as the recurrent, intense fear of panic attacks and the intrusive thoughts and ritualized behaviors of OCD.

“Fluoxetine is considered relevant for easing symptoms across domains involving heightened emotional and behavioral manifestations.”

The medication supports general well-being and contributes to improved comfort during periods of heightened symptoms. It may assist with maintaining functional stability and contributes to easing the overall symptom load by managing distressing manifestations across these varied conditions.


Quick Fact: Relief for Mood and Behavior
Fluoxetine is relevant for easing symptoms of low mood, anxiety, and specific compulsive/impulsive patterns.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Fluoxetine: Official Eligibility Rules

The eligibility for Fluoxetine use is strictly defined by regulatory documents, focusing on patient characteristics and pre-existing conditions.

Absolute Contraindications

Fluoxetine is contraindicated and must not be used in specific patient groups:

  • Patients with a known hypersensitivity to fluoxetine or any component of the formulation.
  • Patients concurrently using Monoamine Oxidase Inhibitors (MAOIs), including Linezolid or intravenous Methylene Blue, due to the risk of serious reactions. A mandatory washout period is required.
  • Co-administration with Pimozide is also contraindicated.

Age and Organ Function Restrictions

Population Group Regulatory Status
Pediatric (MDD) Approved for ages 8 and older (Major Depressive Disorder).
Pediatric (OCD) Approved for ages 7 and older (Obsessive-Compulsive Disorder).
Hepatic Impairment Conditional use; a lower or less frequent dose is required due to reduced drug clearance.
Unstable Epilepsy Not recommended; must be discontinued if seizures develop.

Life Stage Restrictions

Use during pregnancy is restricted to cases where the regulatory assessment determines the benefit outweighs the potential risk. Use while lactating (breastfeeding) is generally not recommended.

What should I know about interactions with other medicines?

Fluoxetine Interactions with Other Medicines and Products

This section outlines interactions officially documented in government regulatory sources, strictly detailing necessary constraints and prohibitions.


Contraindicated and Restricted Combinations

Classification Interacting Agents Constraints
Contraindicated MAOIs (including Linezolid, IV Methylene Blue) Prohibited due to severe Serotonin Syndrome risk.
Contraindicated Pimozide, Thioridazine Prohibited due to risk of QTc prolongation and elevated drug levels.

Pharmacokinetic and Pharmacodynamic Interactions

Fluoxetine is officially documented as a potent inhibitor of the CYP2D6 enzyme pathway. This metabolic effect can reduce the clearance and increase the plasma concentrations of many co-administered medicines that are metabolized by this enzyme, such as certain Tricyclic Antidepressants, Phenytoin, and Carbamazepine.

Pharmacodynamic interactions include an increased risk for Serotonin Syndrome when combined with other serotonergic agents (e.g., Triptans, Tramadol, Lithium). There is also an increased potential for bleeding when used with agents that affect blood coagulation (e.g., NSAIDs, Warfarin).


Timing and Population Notes

A mandatory 5-week waiting period must pass after stopping fluoxetine before initiating an MAOI or Thioridazine. Conversely, fluoxetine should not be started within 14 days of stopping an MAOI. In individuals with hepatic impairment, the elimination half-life of fluoxetine is prolonged, increasing the potential for drug accumulation and interaction with other medications.

Mechanism of Action

Primary Mechanism: Selective Serotonin Reuptake Inhibition

Fluoxetine acts primarily by blocking the Serotonin Transporter (SERT) protein, which results in an immediate increase in serotonin (5-HT) concentration in the synaptic cleft. This targeted mechanism modifies serotonergic signaling by modulating signaling within pathways associated with altered physiological activity.

Adaptive Downstream Receptor Changes

The resulting prolonged elevation of serotonin levels initiates a crucial, delayed mechanistic cascade involving the desensitization and downregulation of certain 5-HT receptors over time. This required cellular adjustment within the neural feedback system drives changes in feedback mechanisms and influences the sustained activity pattern within the targeted pathways.

Secondary Modulation of 5-HT2C Receptor

A distinct, secondary mechanistic activity involves Fluoxetine's action as an antagonist at the 5-HT2C receptor. This targeted blockade of a specific receptor subtype supports the modulation of particular signal transduction events, altering the influence of elevated mediator activity on downstream pathways and influencing downstream signaling events that differentiate the drug's mechanistic profile.

Dosage and Administration Information

Fluoxetine is administered exclusively by the oral route and is supplied in several forms, including immediate-release capsules, tablets, and an oral solution. A delayed-release capsule (90 mg) is also available for once-weekly use. Immediate-release doses are typically taken once daily in the morning and may be taken with or without food. Doses above 20 mg per day may be administered once or split into morning and noon portions.

Indication Starting Dose (Adult) Max Daily Dose (US/EU) Frequency/Timing
MDD / OCD 20 mg once daily 80 mg (US) / 60 mg (EU) Once daily, morning
Bulimia Nervosa 60 mg once daily 60 mg Once daily, morning
Panic Disorder 10 mg once daily for 1 week 60 mg Once daily, morning

Specific procedural conditions apply to certain formulations. The liquid oral solution must be shaken well and measured using a marked device. The 90 mg weekly dose must be initiated seven days following the last 20 mg daily dose of the immediate-release form. Dosage adjustments are required for specific populations; for instance, a lower or less frequent dose should be considered for patients with hepatic impairment, and the daily dose for older adults generally should not exceed 40 mg. If a daily dose is missed, the standard protocol is to skip the missed dose and take the next dose at the usual time; never take two doses to compensate for a forgotten one.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Fluoxetine

Evidence for Use in Major Depressive Disorder (MDD)

The clinical evaluation of Fluoxetine for Major Depressive Disorder (MDD) relies on short-term (acute) and maintenance Randomized Controlled Trials (RCTs) in adults. These studies compared Fluoxetine to an inactive substance (placebo) or other treatments. Researchers primarily monitored changes in symptom scores over periods typically lasting 6 to 12 weeks. Findings describe patterns observed in the studied adult populations regarding changes in severity and the attainment of pre-defined scoring thresholds. Research also monitored the time until the return of symptoms (relapse) in different groups to see if stability persisted. Limited information exists regarding the full extent of long-term functional outcomes beyond the acute phase measurements.


Evidence for Use in Obsessive-Compulsive Disorder (OCD) and Panic Disorder

Fluoxetine was studied for Obsessive-Compulsive Disorder (OCD) in placebo-controlled RCTs that examined the frequency and severity of obsessive thoughts and compulsive behaviors in adults and children/adolescents. For Panic Disorder, evidence is derived from placebo-controlled trials primarily evaluating the frequency of panic attacks over defined time intervals. For both conditions, follow-up durations were often limited to the acute phase, and research regarding long-term persistence of initial changes is not fully established.


Evidence in Specific and Special Populations

Research has evaluated Fluoxetine in specific groups, including children and adolescents for MDD and OCD, and geriatric patients (older adults) for MDD. These trials examined symptom patterns using specific rating scales for each age group. Findings in these special populations were sometimes mixed, with some analyses describing greater variability in reported outcomes. Therefore, data for certain groups remain insufficient, and research findings apply only to the specific populations studied within the confines of the clinical trials.


What Research Gaps and Uncertainty Remain

The available evidence contributes to understanding symptom patterns, but several limitations are noted. Follow-up durations were limited across many indications, meaning there is limited information for long-term functional stability. Comparative evidence (head-to-head research against non-pharmacological therapies) is often lacking. Additionally, results were inconsistent across studies, and findings were mixed for some outcomes or specific subgroups. Evidence provides context but not individual predictions; the research does not determine whether an individual will respond similarly.

Key Studies & References Fluoxetine (oral route) - Mayo Clinic Drug Information

Frequently Asked Questions (FAQ)

Common questions about Fluoxetine (FAQ)

Q: Is Fluoxetine the same type of medicine as Zoloft or Lexapro?

Regulatory documents classify Fluoxetine as a Selective Serotonin Reuptake Inhibitor (SSRI). This classification describes how the medication works on the neurotransmitter serotonin in the brain. Other medications like sertraline (Zoloft) and escitalopram (Lexapro) also belong to the SSRI class of drugs.


Q: What is the difference between Fluoxetine and Prozac?

Prozac is one of the brand names used for the medication with the active ingredient Fluoxetine. According to official sources, a generic version and the brand-name product contain the same medicinal component.


Q: Does Fluoxetine cause weight gain or weight loss?

Official drug labels list altered appetite and weight as a potential adverse reaction. Furthermore, regulatory documents state that some patients have experienced significant weight loss while taking this medication.


Q: How long does it typically take for Fluoxetine to start working?

Studies and official information indicate that Fluoxetine and its active form take time to build up in the body. It typically reaches what is called steady-state concentrations—a stable level in the blood—after 4 to 5 weeks of continuous use.


Q: Can Fluoxetine make anxiety worse at first?

Official drug labeling includes anxiety and nervousness as common adverse reactions reported during clinical trials. These feelings are noted to have occurred during treatment with Fluoxetine.


Q: Is it true that Fluoxetine can affect sleep?

According to the official product information, Fluoxetine can affect sleep patterns. Common adverse reactions include insomnia (difficulty falling or staying asleep), somnolence (drowsiness), and **abnormal dreams).


Q: What are the most common side effects people report when starting Fluoxetine?

Regulatory documents state that common adverse reactions reported in clinical trials when starting Fluoxetine include nausea, headache, insomnia, somnolence, and anxiety. Other common reports include nervousness, anorexia (loss of appetite), and tremor.


Q: Can Fluoxetine cause problems with sexual function?

Yes, sexual dysfunction is listed in official documents as a common adverse reaction associated with Fluoxetine use. This can include decreased sex drive and issues with ejaculation or orgasm.


Q: What is Serotonin Syndrome and is Fluoxetine related to it?

Official drug labels include a warning that Serotonin Syndrome can occur in patients taking Fluoxetine. This is a potentially serious condition related to excessive serotonin activity in the central nervous system. The risk is noted to increase when Fluoxetine is taken with other medications that also increase serotonin levels.


Q: What is the risk of dependence or addiction with Fluoxetine?

Official documentation states that Fluoxetine has not been systematically studied for its potential for abuse, tolerance, or physical dependence in humans or animals.


Q: Is Fluoxetine suitable for teenagers or children?

Official sources state that Fluoxetine is approved for use in certain children and adolescents for specific conditions. However, the medication is not approved for use in children under 7 years of age.


Q: Can I take pain relievers like Ibuprofen or Tylenol while on Fluoxetine?

Regulatory documents state that Fluoxetine may increase the risk of bleeding when taken with Nonsteroidal Anti-inflammatory Drugs (NSAIDs), which includes ibuprofen. Specific caution regarding this interaction is noted in official drug labeling.


Q: Are there any herbal supplements I should not mix with Fluoxetine?

Official regulatory sources specifically note that using the herbal supplement St. John's Wort (Hypericum perforatum) may lead to an increased risk of serotonergic effects.


Q: Does Fluoxetine interact with alcohol?

According to official product information, the combination of Fluoxetine and alcohol is generally not recommended, and avoiding alcohol is generally recommended.


Q: What should I know about the 'black box warning' for Fluoxetine?

The official U.S. label includes a Boxed Warning. This warning states that antidepressants, including Fluoxetine, increase the risk of suicidal thoughts and behavior in children, adolescents, and young adults (up to age 24) in short-term studies.


Q: How long do people usually stay on Fluoxetine treatment?

Regulatory documents note that for some uses, the effectiveness for long-term use (e.g., beyond 16 weeks) has not been systematically evaluated in controlled trials. This fact guides healthcare providers to periodically re-evaluate the medication's continued usefulness for each patient.


Q: What does it mean that Fluoxetine is an SSRI?

Fluoxetine is classified as a Selective Serotonin Reuptake Inhibitor (SSRI). This term describes its action, which is to selectively inhibit the reuptake of the neurotransmitter serotonin in the central nervous system.


Q: Can Fluoxetine make me feel 'numb' or affect my emotions?

Official labels note the potential for Fluoxetine to impair judgment, thinking, and motor skills, which relates to a person's mental state. Furthermore, adverse reactions like asthenia (unusual weakness or tiredness) and certain emotional changes are reported in official documentation.


Q: What is the evidence that Fluoxetine is effective for anxiety?

Fluoxetine is officially indicated for the treatment of Panic Disorder, which is a type of anxiety disorder. It is also approved for the treatment of generalized anxiety when used in combination with the medication olanzapine.


Q: Does Fluoxetine stay in your system for a long time?

Yes, official sources describe Fluoxetine as having a relatively long elimination half-life of 4 to 6 days. The active substance created when the body processes the drug, norfluoxetine, has an even longer half-life of 4 to 16 days.


Q: What happens when a person decides to stop taking Fluoxetine?

Official regulatory documents describe possible discontinuation adverse reactions that may occur if treatment is stopped suddenly. Reported symptoms include dizziness, sensory disturbances, insomnia, and irritability.


Q: Is it normal to feel tired or fatigued on Fluoxetine?

According to official drug labeling, feeling tired or fatigued may be a possibility. Somnolence (drowsiness) and asthenia (unusual weakness or tiredness) are both listed as common adverse reactions.


Q: Can Fluoxetine affect my blood pressure?

Official documentation lists vasodilation (widening of blood vessels) as an adverse reaction. Additionally, caution is advised for patients with existing heart conditions, including high blood pressure.


Q: Can taking Fluoxetine during pregnancy cause problems for the baby?

Regulatory information suggests that using the medication late in the third trimester of pregnancy may be associated with neonatal complications requiring medical support. Some studies also suggest a small increased risk of persistent pulmonary hypertension in the newborn (PPHN).


Q: Is Fluoxetine safe to take while breastfeeding?

Official documents confirm that Fluoxetine and its active metabolite are excreted in human breast milk. Adverse events in infants exposed through breast milk have been reported, and healthcare professionals must consider the risks versus benefits regarding discontinuation of breastfeeding if treatment is necessary.


Q: What are the risks of taking Fluoxetine if I have liver or kidney problems?

Caution is advised in patients with liver impairment because the drug is processed in the liver; official documents suggest a lower or less frequent dose may be necessary. The drug’s processing is generally not affected by renal (kidney) impairment.


Q: Why do official documents mention suicidal thoughts when talking about this medicine?

The topic is addressed in the Boxed Warning on the official U.S. label. This warning is included because studies showed an increased risk of suicidal thoughts and behavior in children, adolescents, and young adults (up to age 24) during the initial short-term treatment period.


Q: Does Fluoxetine have interactions with blood thinners?

Official regulatory documents warn that Fluoxetine may increase the risk of bleeding. Caution is recommended when taking it with other medications that affect blood coagulation, which includes warfarin (a type of blood thinner).


Q: Can Fluoxetine affect a person's concentration or memory?

Official labeling notes the potential for Fluoxetine to impair judgment, thinking, and motor skills, which relates to a person's ability to concentrate. Furthermore, problems concentrating are listed as a symptom of low sodium levels (hyponatremia), an adverse event reported in the drug's documentation.


Q: What is the mechanism by which Fluoxetine is thought to work?

According to regulatory documents, the official mechanism of action is the selective inhibition of serotonin reuptake. This action increases the amount of the neurotransmitter serotonin available in the central nervous system.


Q: Is there research on the long-term effects of taking Fluoxetine?

Regulatory documents state that the effectiveness for long-term use (e.g., beyond 16 weeks) has not been systematically evaluated in controlled clinical trials for some conditions. Official guidelines recommend periodic re-evaluation by a healthcare provider for long-term use.


Q: Is it possible to be allergic to Fluoxetine?

Yes, official safety warnings advise that if a rash or other allergic phenomena appears, official warnings advise that treatment should be discontinued. This indicates that allergic reactions are a possibility addressed in regulatory documents.


Q: Can Fluoxetine cause headaches?

According to the official drug labeling, headache is listed as one of the common adverse reactions reported during clinical trials.


Q: What is meant by the 'half-life' of Fluoxetine?

The half-life is a medical term that refers to the time it takes for the amount of medication in the body to reduce by half. Regulatory documents note that Fluoxetine has a long half-life of 4 to 6 days.


Q: What age groups are Fluoxetine studies focused on?

Regulatory sources show that studies and approvals cover various age groups. Research has focused on pediatric patients (children and adolescents), adults, and geriatric patients (those aged 65 and older).


Q: Does Fluoxetine affect the menstrual cycle?

Official documentation indicates that changes to the menstrual cycle may be possible. Specifically, heavy menstrual periods have been reported as an adverse reaction in adolescents taking the medication.


Q: Can people with bipolar disorder take Fluoxetine?

Official warnings advise healthcare providers to screen patients for bipolar disorder before starting treatment. This is because the activation of mania or hypomania has been noted to occur during treatment with this medication.


Q: What other mental health medications are commonly listed as interactions with Fluoxetine?

Official documents warn about potential interactions with several classes of mental health medications. This includes Monoamine Oxidase Inhibitors (MAOIs), other serotonergic drugs, and certain antipsychotics or other antidepressants.


Q: How does Fluoxetine interact with St. John's Wort?

Official regulatory sources specifically warn that the use of the herbal supplement St. John's Wort may lead to an increased risk of serotonergic effects in the body.


Q: Is there a maximum time a person can safely be on Fluoxetine?

Regulatory documents note that the effectiveness for long-term use for certain conditions has not been systematically evaluated in controlled trials. Official guidelines recommend periodic re-evaluation by a healthcare provider for long-term use.


Q: If I have a history of seizures, can I take Fluoxetine?

Regulatory warnings advise caution for patients with a history of seizures. Caution is also noted for those with other conditions that potentially lower the seizure threshold.

How should Fluoxetine be stored and disposed of?

The storage and disposal of Fluoxetine must adhere strictly to the conditions specified in official regulatory documents to maintain its stability and ensure safety.

Official Storage Requirements

Detail Regulatory Requirement
Temperature Store at controlled room temperature, 20 C to 25 C (68 F to 77 F) [1, 2].
Protection Must be protected from moisture and stored in the original container [3, 4].
Child Safety Must be kept out of the sight and reach of children [1, 4].

Disposal Instructions

Detail Regulatory Instruction
Method Dispose of unused product according to local requirements; using a drug take-back program is preferred [2].
Restriction Do not flush the medicine down the toilet or pour into a drain unless specifically instructed by official labeling [2].

Fluoxetine must be stored within the specified temperature range with the container tightly closed to preserve its integrity. Official instructions guide users to follow local regulations for disposal, prioritizing authorized collection points for unused medication.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fluoxetine found in:

A-Z Index: